DMAE as sole agent for the treatment of mild cognitive impairment

Details for Australian Patent Application No. 2007316137 (hide)

Owner Pierre Fabre Medicament

Inventors Przybylski, Christophe; Fabre, Pierre; Dubois, Bruno

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007316137

PCT Pub. Number WO2008/053011

Priority 0609548 31.10.06 FR

Filing date 31 October 2007

Wipo publication date 8 May 2008

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/053011 Priority application(s): WO2008/053011

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007316140-Method for producing a twist metal closure with seperate disc and ring from a single closure blank

2007316114-Cement silo structure for mining machine